Skip to main content
NGEN
NYSE Life Sciences

NervGen Pharma Corp. Approved for Nasdaq Listing, Enhancing Market Access

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$5.9
Mkt Cap
$475.175M
52W Low
--
52W High
--
52W Position
Off High
Rel. Volume
Market data snapshot near publication time

Summary

NervGen Pharma Corp. announced its common shares have been approved for listing and began trading on Nasdaq, a move expected to boost market visibility and liquidity.


Key Events · Financing and Capital Events · NGEN

  • Nasdaq Listing Approval

    NervGen Pharma Corp.'s common shares received approval for listing on the Nasdaq stock exchange.

  • Commencement of Trading

    The company's common shares began trading on Nasdaq as of January 8, 2026, under the ticker symbol 'NGEN'.


Analysis · NGEN · Life Sciences

NervGen Pharma Corp.'s common shares have been approved for listing and commenced trading on Nasdaq under the symbol 'NGEN'. This move is a significant positive development for the company, as it typically leads to increased visibility among institutional investors, improved trading liquidity, and broader access to capital markets. The listing on a major U.S. exchange can enhance the company's profile and potentially attract a wider investor base, supporting future growth and financing initiatives.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NGEN was trading at $5.90 on NYSE in the Life Sciences sector, with a market capitalization of approximately $475.2M. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NGEN - Latest Insights

NGEN
Nov 16, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.95
Real-time Price: $1.95 info
Change: $0 (0%) info
Market Cap: $198.552M info
NGEN
Nov 12, 2026, 7:15 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.52
Real-time Price: $1.95 info
Change: +$0.430 (+28%) info
Market Cap: $198.552M info
NGEN
Oct 16, 2026, 4:31 PM EDT
Filing Type: 6-K/A
Importance Score:
8
Price at Filing: $1.59
Real-time Price: $1.95 info
Change: +$0.360 (+23%) info
Market Cap: $198.552M info
NGEN
Oct 16, 2026, 4:30 PM EDT
Filing Type: 40-F/A
Importance Score:
8
Price at Filing: $1.59
Real-time Price: $1.95 info
Change: +$0.360 (+23%) info
Market Cap: $198.552M info
NGEN
Sep 25, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.86
Real-time Price: $1.95 info
Change: +$0.090 (+5%) info
Market Cap: $198.552M info